TY - JOUR T1 - Cardiovascular risks of stopping antiplatelet therapy before non-cardiac surgery for patients with coronary stents JF - Evidence Based Medicine JO - Evid Based Med SP - 122 LP - 123 DO - 10.1136/ebmed.2011.100381 VL - 17 IS - 4 AU - Thomas M Maddox Y1 - 2012/08/01 UR - http://ebm.bmj.com/content/17/4/122.abstract N2 - Commentary on: Albaladejo P, Marret E, Samama CM, et al. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart 2011;97:1566–72.OpenUrlAbstract/FREE Full Text The use of stents in percutaneous coronary intervention (PCI) increases procedural success and decreases restenosis, but it complicates subsequent surgical procedures in these patients.1 Between 5% and 15% of PCI patients undergo non-cardiac surgery in the year following PCI, and are at high risk of experiencing cardiovascular (CV) complications.2 The most serious risk is stent thrombosis, which occurs in 2.5% of patients and is fatal in 40%.3 Although guidelines for the management of these patients are available, the evidence supporting them is lacking.4 Key questions remain regarding contemporary … ER -